Neuraxis is a medical device company that has developed a new system to deliver safe and controlled localized therapeutic hypothermia directly to injured or at-risk tissue during surgery. The Neuraxis team includes leaders in spinal cord injury research, orthopedic surgery, and neurosurgery who aim to reduce neural and spinal cord injuries through the company’s novel therapies.
Boomerang Catapult invested in Neuraxis in 2022, motivated by the company’s potential to contribute to the regional medical technology cluster through strong and deepening connections between Neuraxis’s growth and Traverse City.
  • TAGS